190 related articles for article (PubMed ID: 24033102)
1. Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology.
McMillan A; Ardeshna KM; Cwynarski K; Lyttelton M; McKay P; Montoto S;
Br J Haematol; 2013 Oct; 163(2):168-81. PubMed ID: 24033102
[TBL] [Abstract][Full Text] [Related]
2. Guideline for the diagnosis and management of myelofibrosis.
Reilly JT; McMullin MF; Beer PA; Butt N; Conneally E; Duncombe A; Green AR; Michaeel NG; Gilleece MH; Hall GW; Knapper S; Mead A; Mesa RA; Sekhar M; Wilkins B; Harrison CN;
Br J Haematol; 2012 Aug; 158(4):453-71. PubMed ID: 22651893
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the laboratory investigation of heritable disorders of platelet function.
Harrison P; Mackie I; Mumford A; Briggs C; Liesner R; Winter M; Machin S;
Br J Haematol; 2011 Oct; 155(1):30-44. PubMed ID: 21790527
[TBL] [Abstract][Full Text] [Related]
4. Guideline on aspects of cancer-related venous thrombosis.
Watson HG; Keeling DM; Laffan M; Tait RC; Makris M;
Br J Haematol; 2015 Sep; 170(5):640-8. PubMed ID: 26114207
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline.
Pratt G; El-Sharkawi D; Kothari J; D'Sa S; Auer R; McCarthy H; Krishna R; Miles O; Kyriakou C; Owen R
Br J Haematol; 2022 Apr; 197(2):171-187. PubMed ID: 35020191
[TBL] [Abstract][Full Text] [Related]
6. Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Follows GA; Barrington SF; Bhuller KS; Culligan DJ; Cutter DJ; Gallop-Evans E; Kassam S; Osborne W; Sadullah S; Townsend W; Uttenthal BJ; Collins GP;
Br J Haematol; 2022 Jun; 197(5):558-572. PubMed ID: 35191541
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).
Peñalver FJ; Sancho JM; de la Fuente A; Olave MT; Martín A; Panizo C; Pérez E; Salar A; Orfao A;
Haematologica; 2017 Feb; 102(2):235-245. PubMed ID: 27846613
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline - response to Griffin et al.
McMillan A; Ardeshna KM; Cwynarski K; Lyttelton M; McKay P; Montoto S
Br J Haematol; 2014 Nov; 167(4):579-80. PubMed ID: 25040195
[No Abstract] [Full Text] [Related]
9. The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper.
McKay P; Wilson MR; Chaganti S; Smith J; Fox CP; Cwynarski K;
Br J Haematol; 2020 Sep; 190(5):708-714. PubMed ID: 32433789
[No Abstract] [Full Text] [Related]
10. Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.
Cheung CW; Burton C; Smith P; Linch DC; Hoskin PJ; Ardeshna KM
Br J Haematol; 2005 Oct; 131(2):193-200. PubMed ID: 16197449
[TBL] [Abstract][Full Text] [Related]
11. Guideline for the management of conception and pregnancy in thalassaemia syndromes: A British Society for Haematology Guideline.
Shah FT; Nicolle S; Garg M; Pancham S; Lieberman G; Anthony K; Mensah AK
Br J Haematol; 2024 May; ():. PubMed ID: 38715390
[TBL] [Abstract][Full Text] [Related]
12. Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.
Santambrogio E; Nicolosi M; Vassallo F; Castellino A; Novo M; Chiappella A; Vitolo U
Expert Rev Hematol; 2019 Sep; 12(9):787-796. PubMed ID: 31305170
[No Abstract] [Full Text] [Related]
13. Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline.
Griffin M; Goddard K; Morley N; Went R; Fletcher A; Wright J
Br J Haematol; 2014 Nov; 167(4):577-9. PubMed ID: 24909921
[No Abstract] [Full Text] [Related]
14. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Kansara R
Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
[TBL] [Abstract][Full Text] [Related]
15. CNS prophylaxis in lymphoma: who to target and what therapy to use.
Hill QA; Owen RG
Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838
[TBL] [Abstract][Full Text] [Related]
16. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.
Villa D; Connors JM; Sehn LH; Gascoyne RD; Savage KJ
Haematologica; 2011 Jul; 96(7):1002-7. PubMed ID: 21486867
[TBL] [Abstract][Full Text] [Related]
17. Prevention of CNS relapse in diffuse large B-cell lymphoma.
Kridel R; Dietrich PY
Lancet Oncol; 2011 Dec; 12(13):1258-66. PubMed ID: 21933751
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era.
Fletcher CD; Kahl BS
Leuk Lymphoma; 2014 Oct; 55(10):2228-40. PubMed ID: 24286262
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH; Thiel E
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680
[TBL] [Abstract][Full Text] [Related]
20. Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis.
Laskin JJ; Savage KJ; Voss N; Gascoyne RD; Connors JM
Leuk Lymphoma; 2005 Dec; 46(12):1721-7. PubMed ID: 16263574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
